Analysts expect Bluejay Diagnostics, Inc. to report revenue of 0.00 for Q4 23, against a range of 0.00 to 0.00.
| Metric | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | - | - | - | - | - | - | - | |||||||||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.29 M | 1.35 M | 1.27 M | |||||||||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.10 M | 1.11 M | 1.15 M | |||||||||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.19 M | 1.23 M | 1.21 M |
Analysts expect Bluejay Diagnostics, Inc. to report earnings per share of -877.03 for Q4 23, against a range of -911.51 to -842.55. The most recent reported quarter, Q3 23, came in at -3,330.00, a 145.2% miss against the -1,358.03 consensus.
| Metric | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -4,400.00 | -3,330.00 | - | - | - | - | - | - | - | - | |||||||||||||||||
| High Estimate | -1,134.22 | -1,277.67 | -842.55 | -1,126.41 | -144.19 | -138.89 | -140.08 | -1,378.70 | 227.47 | 488.77 | |||||||||||||||||
| Low Estimate | -1,349.00 | -1,438.39 | -911.51 | -1,333.23 | -158.69 | -167.43 | -162.28 | -1,644.70 | 190.53 | 423.33 | |||||||||||||||||
| Consensus Estimate | -1,241.61 | -1,358.03 | -877.03 | -1,229.82 | -151.44 | -153.16 | -151.18 | -1,511.70 | 209.00 | 456.05 |